Description

Chinese Journal of Contemporary Neurology and Neurosurgery (CJCNN, ISSN 1672-6731, www.xdjb.org, www.cjcnn.org) is the official journal of Chinese Medical Doctor Association, Tianjin Science and Technology Association, Tianjin Neuroscience Society and Tianjin Huanhu Hospital. CJCNN aims to facilitate international collaboration and exchange ofcomprehensive and cutting-edge information on basic, translational, and applied clinical research in neurology and neurosurgery. Prevention, treatment and research relevant to China is a focus area, but submissions from all regions are welcomed. CJCNN was launched in October, 2001 with an international Editorial team having a unique mix of Asian andWestern participation.

CJCNN is an international multidisciplinary peer⁃reviewed monthly Chinese journal that publishes editorials, original full⁃length research articles, short communications, reviews, methodological papers, commentaries, perspectives and short reportsin the broad fields of developmental, molecular, cellular, systematic, computational, behavioral, cognitive and clinical neurosciences.

CJCNN has been indexed by EMBASE/SCOPUS, Chemical Abstracts (CA), DOAJ, EBSCO-CINAHL, Global Health, Index Copernicus, HINARI, ProQuest, RCCSE, CBM, CNKI, Wanfang Data, etc.

Submission to the journal

Full-length original research articles, review articles and Editorials on clinical and basic aspects of topics represented by the fields of interest of neurology and neurosurgery are welcome. Short communications and Case Reports should be focused on major new developments of general interest to the neurology and neurosurgery readership.

Manuscripts should be submitted online at http://www.cjcnn.org.

Editorial Office: Chinese Journal of Contemporary Neurology and Neurosurgery

No. 6 Jizhao Road, Jinan District, Tianjin 300350, China

Tel: 0086-22-59065611

Fax: 0086-22-59065631

Email: xdsjjbzz@263.net.cn

In a covering letter, please identify the person responsible for editorial correspondence (address, telephone and fax numbers, mobile phone and Email address). All authors should have made substantial contributions to all of the following: 1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be submitted. Also include details of any previous submission.

Acknowledgements

All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section.

Randomized controlled trials

Chinese Journal of Contemporary Neurology and Neurosurgery recommends that authors adopt the proposal from the International Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phaseⅠtrials) would be exempt. Further information can be found at External link www.icmje.org.

Ethics

Work on human beings that is submitted to Chinese Journal of Contemporary Neurology and Neurosurgery should comply with the principles laid down in the Declaration of Helsinki (the seventh revision at the 64th World Medical Assembly meeting on October 2013 in Fortaleza, Brazil). The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which itwas performed and that subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with institution guidelines. Patients' and volunteers' names, initials, and hospital numbers should not be used.

Conflict of interest

At the end of the text, under a subheading "Conflict of interest statement" all authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Role of the funding source

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Peer-review policy

Only manuscripts of high relevance and suitability will enter into the peer review process, which will be conducted by at least two internationally known experts in scientific knowledge. Authors may suggest decision of acceptance or rejection rests with suitability will enter into the peer review process, which will be conducted by the field, and will aim to ensure that all published manuscripts provide new that specific individuals be or not be involved as reviewers, but the final the Editorial board.

Editorial policies

Submission of a manuscript to Chinese Journal of Contemporary Neurology and Neurosurgery implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non- commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.

File formats

The following word processor file formats are acceptable for the main manuscript document:

∗Microsoft Word (2000 and above)

∗Portable Document Format (PDF)

Structure of manuscripts

Manuscripts in general should be organized in the following order:

Title (should be clear, descriptive and not too long)

Name(s) of author(s)

Complete postal address of affiliations

Full telephone, Fax No. and Email address of the corresponding author

Present address of author(s) if applicable

Complete correspondence address and Email address to which the proofs should be sent

Abstract, a structured abstract. Background and objective, Methods, Results and Conclusion

Key words (indexing terms), a list of 3-10 key words (listed in MeSH Major Topic) must be provided with every article

Introduction

Material studied, area descriptions, methods, techniques

Results

Discussion

Conclusion

Acknowledgements, Conflict of interest statement, and Acknowledgement of the role of the funding source for the study

References

Tables and Figures

1. SI units should be used.

2. CJCNN reserves the privilege of returning to the author for revision accepted manuscripts and illustrations which are not in the proper form given in this guide.

References

Should be numbered in the order they appear within the manuscript; in the text they should be referred to by numbers in square brackets on the superscript. The abbreviations of journal titles should conform to Index Medicus/MEDLINE.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.

In the reference list, periodicals ^[1], single author books ^[2] and multi-author books ^[3] should accord with the following examples:

[1] Butts CA, Bodkin D, Middleman EL, Englund CW, Ellison D, Alam Y, Kreisman H, Graze P, Maher J, Ross HJ, Ellis PM, McNulty W, Kaplan E, Pautret V, Weber MR, Spepherd FA. Randomized phaseⅡ study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer[J]. J Clin Oncol, 2007, 25:5777⁃5784.

[2] Zhang ZN. Criteria of diagnosis and therapeutic response in hematologic diseases[M]. 2nd ed. Beijing: Scientific Publication, 1998: 168⁃360.

[3] Weinsetin L, Suarty MN. Pathogenic properties of invading microorganism[M]//Sodeman WA Jr, Sodeman WA. Pathologic physiology: mechanisms of diseases. Philadelphia: W.B. Saunders, 1974: 457⁃472.

Figures and figure legends

Figures should be provided as separate files and should not be included in the main text of the submitted manuscript. Each figure should comprise only a single file in TIFF (preferred format for pathological images) or JPEG (preferred format for photographic and radiological images). Color images must be in RGB (red, green, blue) mode. Include the font filesfor any text. Figures wider than 1 column should be between 10.50 and 18.00 cm wide. Do not save figure numbers,legends, or author names as part of the image. Individual figure files should not exceed 10 MB. Images should not exceed 500 pixels per inch in width or height. Figures will be resized during publications of final full text. The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: figure number (in sequence,using Arabic numerals, i.e. Figure 1, Figure 2, Figure 3, etc); short title of figure (maximum 15 words); detailed legend, upto 300 words.

Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere. In order for all figures to be open access, authors must have permission from the rights holder if they wish to include images that have been publised elsewhere in non open access journals.

Tables

Tables should be numbered and cited in the text in sequence using Arabic numerals (i.e. Table 1, Table 2 etc.).  Table titles (maximum 15 words) should be included above the table, and legends (maximum 300 words) should be included underneath the table.  Tables less than one A4 page in length can be placed in the appropriate location within the manuscript.  Tables larger than one A4 page in length can be placed at the end of the document text file.  Please cite and indicate where the table should appear at the relevant location in the text file so that the table can be added in the correct place during production.  Tables should not be embedded as figures or spreadsheet files, but should be formatted using “Table object” function in your word processing program.  Color and shading may not be used.  Commas should not be used to indicate numerical values.

Copyright

Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement".

Proofs

One set of page proofs in PDF format will be sent by Email to the corresponding author. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.

Offprints

The corresponding author, at no cost, will be provided with a PDF file of the article via Email. Offprints will be sent to the corresponding author if the author asks for them by post.

Publication charges

The cost of a limited number of illustrations is borne by the Journal. A charge of each manuscript submission is US $25. The cost for color photographs (US $ 70 per page) is defrayed by the authors. A charge of US $ 55 per printed page will be levied on all manuscripts accepted. We offer a complete or partial fee waiver for authors who do not have funds to cover publication fees. Editors and reviewers have no access to payment information, and hence inability to pay will not influence the decision to publish a paper.